A Phase 4 interventional study of Ibuprofen and Acetaminophen in Opioid Use and Pain, Postoperative, sponsored by The University of Texas Health Science Center, Houston. Completed at 1 site in United States. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-02.
Sponsored by The University of Texas Health Science Center, Houston · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Pain, Postoperative by The University of Texas Health Science Center, Houston — 1 open to participants now, 1 under way, none of them phase 3. Pain, Postoperative · The University of Texas Health Science Center, Houston.
Among the 18 studies in Pain, Postoperative by The University of Texas Health Science Center, Houston, this one is the 2nd largest by enrollment of the 16 interventional ones that give a count, is the only one that started in 2017, is one of 13 in phase 4, and was the 6th registered.
5,675 studies on the registry are indexed under Pain, Postoperative; 1,241 are open to participants now.
Browse Pain, Postoperative studies →1 of the 18 studies in Pain, Postoperative by The University of Texas Health Science Center, Houston is open now, in 1 country. Recruiting first, the newest first:
The University of Texas Health Science Center, Houston · Sites in United States
Ages 18+ · Women only
By country, each count listing its studies:
Of the 677 Pain, Postoperative studies recruiting now, 240 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years to 50 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 1 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 170 is above the median of 75 across 4,850 interventional studies indexed under Pain, Postoperative.
Median enrollment 55 across the 16 interventional studies, 667 across the 2 observational. Of the 12 that completed or were terminated, 9 (75%) have results posted.
This tab as a report to print or save as PDF → With an account.
The University of Texas Health Science Center, Houston is the lead sponsor of 899 studies on the registry; 214 are open to participants now.
Of its 174 completed or terminated interventional studies of FDA-regulated products, 142 (82%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Pain, Postoperative by The University of Texas Health Science Center, Houston, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Postpartum patients delivered by cesarean section will be randomized to NSAIDS Vs NSAIDS plus opioid
Women will be approached priors to discharge from the hospital, if they meet inclusion criteria and consent for the study, they will be randomized to one of two possible analgesic regimens. They will be followed at 1-2 weeks and 4-6 weeks after discharge to assess pain level.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
women that had a C-section will be discharged home with prescriptions for ibuprofen and acetaminophen
Drug: Ibuprofen · Drug: Acetaminophen
women that had a C-section will be discharged home with prescriptions for ibuprofen and acetaminophen/hydrocodone (Norco)
Drug: Ibuprofen · Drug: Norco
NSAID
analgesic
Drug pages: HydrocodoneStudies of HydrocodoneHydrocodone pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record. · AcetaminophenStudies of AcetaminophenAcetaminophen pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
acetaminophen plus opioid
Pain Level
pain level measured by objective and subjective scales. 1- Objective scale: visual analogue pain score (VAS). It is a 100 mm line, patients will be instructed to mark a point in the line that represents their pain level. A point towards the left will mean "less pain" and a point towards the right will mean "more pain". After the patient makes a selection, the research team will measure where the selected point is (in cm). minimum measurement =0mm = no pain. maximum measurement=100mm=worst pain.
Time frame: 2-4 weeks postpartum
Patient Satisfaction
patient satisfaction as measured by the following scale: 1(very dissatisfied) 2(somewhat dissatisfied) 3(neutral) 4(satisfied) 5(very satisfied)
Time frame: 2-4 weeks postpartum
recruitment start date: 12/2017 recruitment end date: 03/2018
| Milestone | Ibuprofen Plus Acetaminophen | Ibuprofen Plus Acetaminophen/Hydrocodone |
|---|---|---|
| Started | 85 | 85 |
| Completed | 76 | 81 |
| Not completed | 9 | 4 |
pain level measured by objective and subjective scales. 1- Objective scale: visual analogue pain score (VAS). It is a 100 mm line, patients will be instructed to mark a point in the line that represents their pain level. A point towards the left will mean "less pain" and a point towards the right will mean "more pain". After the patient makes a selection, the research team will measure where the selected point is (in cm). minimum measurement =0mm = no pain. maximum measurement=100mm=worst pain.
| millimeters on a scale | Ibuprofen Plus Acetaminophen | Ibuprofen Plus Acetaminophen/Hydrocodone |
|---|---|---|
| Pain Level | 12.3 ± 19.5 | 15.9 ± 20.4 |
patient satisfaction as measured by the following scale: 1(very dissatisfied) 2(somewhat dissatisfied) 3(neutral) 4(satisfied) 5(very satisfied)
| Participants | Ibuprofen Plus Acetaminophen | Ibuprofen Plus Acetaminophen/Hydrocodone |
|---|---|---|
| 1(very dissatisfied) | 2 | 4 |
| 2(somewhat dissatisfied) | 3 | 3 |
| 3(neutral) | 11 | 12 |
| 4(satisfied) | 23 | 16 |
| 5(very satisfied) | 37 | 46 |
Collected over four months. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Ibuprofen Plus Acetaminophen | 0/85 (0%) | 0/85 (0%) | 14/85 (16.5%) |
| Ibuprofen Plus Acetaminophen/Hydrocodone | 0/85 (0%) | 0/85 (0%) | 25/85 (29.4%) |
| Event | Ibuprofen Plus Acetaminophen | Ibuprofen Plus Acetaminophen/Hydrocodone |
|---|---|---|
| constipationGastrointestinal disorders | 7/85 | 13/85 |
| somnolenceGeneral disorders | 4/85 | 13/85 |
| nausea / emesisGastrointestinal disorders | 2/85 | 4/85 |
| GERDGastrointestinal disorders | 1/85 | 2/85 |
| itchingGeneral disorders | 1/85 | 2/85 |
| Age, Continuous(years) | Ibuprofen Plus Acetaminophen | Ibuprofen Plus Acetaminophen/Hydrocodone | Total |
|---|---|---|---|
| Mean | 28.39 ± 5.8 | 28.05 ± 5.64 | 28.2 ± 5.7 |
| Sex: Female, Male(Participants) | Ibuprofen Plus Acetaminophen | Ibuprofen Plus Acetaminophen/Hydrocodone | Total |
|---|---|---|---|
| Female | 85 | 85 | 170 |
| Male | 0 | 0 | 0 |
| Race/Ethnicity, Customized(Participants) | Ibuprofen Plus Acetaminophen | Ibuprofen Plus Acetaminophen/Hydrocodone | Total |
|---|---|---|---|
| Race — African american | 36 | 49 | 85 |
| Race — Hispanic | 34 | 29 | 63 |
| Race — white | 13 | 3 | 16 |
| Race — other | 2 | 4 | 6 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided
Ran from Dec 2017 to primary completion in Apr 2018, 3 months.
Results were first posted in Jul 2019, 1 year 2 months after primary completion.
Of 533 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's 3 months is below that.
Counting every sponsor, half of 543 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Texas Health Science Center, Houston →